Tactic Links - Organic Traffic Booster - Home

Path: Home > List > Load (astrazenecaconnect.net)

domain	astrazenecaconnect.net
summary	AstraZeneca’s CALQUENCE (akalabrutinib) has been approved in Europe for treating adults with previously untreated chronic lymphocytic leukemia (CLL). The drug is indicated for monotherapy or in combination with obinutuzumab, and for patients with CLL who have received prior treatment. Research and treatment efforts aim to improve patient adherence and quality of life, particularly with medications approved for advanced lung cancer treatment.
title	Information for healthcare professionals \| AZ Connect
description	On our AstraZeneca Connect service portal, we have collected information that you as a healthcare professional may often need.
keywords	diabetes, till, cancer, information, study, quiz, event, academy, material, prostate, patient
upstreams
downstreams
nslookup	A 217.114.94.2
created	2025-11-08
updated	2026-02-02
summarized	2026-02-03